News

View the latest business news about the world's top companies

Logo
Tonix Pharmaceuticals announces agreement to acquire infectious disease R&D facility to accelerate development of Vaccines and Antiviral Drugs

CHATHAM, N.J., July 27, 2021 – Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a Purchase and Sale...

By  Pavankumar On  2021-07-27 18:49:00
Logo
Marlboro maker Phillip Morris to stop selling cigarettes in UK, supporting government ban

Tobacco company Philip Morris International has said that it intends to quit selling cigarettes in the United Kingdom in ten years. The company's famous Marlboro brand will be phased out of British st...

By  Ishika Dangayach On  2021-07-26 20:12:00
Logo
Biogen’s Alzheimer’s drug generates $2 million in first few weeks

The controversial Alzheimer's drug by Biogen generated $2 million in revenue in the first few weeks of approval, said the company on Thursday. The company posted better-than-expected quarterly earning...

By  Shubhangi On  2021-07-23 02:19:00
Logo
Biogen’s Alzheimer drug suffers setback as hospitals decline its use

Biogen Inc's drug for Alzheimer's disease, Aduhelm, suffered another setback on Thursday as large hospitals declined to use it. One of the largest health-system in US, Cleveland Clinic and New York's ...

By  Shubhangi On  2021-07-16 03:43:00
Logo
Skylight Health acquires ACO Partners and enters value-based contracting for traditional medicare patients

Skylight Health Group Inc. [SHGFD] ("Skylight Health" or the "Company"), a multi-state primary care group in the United States, today announced the acquisition of ACO Partners LLC ("AP"), a new Accoun...

By  Hemanth On  2021-07-15 02:07:00
Logo
Moderna jumps to all-time high after its vaccine shows promising result against Delta variant

Moderna Inc share jumped to a record high on Tuesday, after the drugmaker said its COVID-19 vaccine showed promising results in a lab setting against the Delta variant, first found in India, which cle...

By  Arghyadeep On  2021-06-29 22:23:00
Logo
Walmart launches low-price private brand analog insulin

Walmart launched the first-ever private brand analog insulin on Tuesday, giving a significant discount on diabetic prescription medication. Adults and children with a prescription will be able to purc...

By  Ishika Dangayach On  2021-06-29 21:25:00
Logo
uniQure to Acquire Corlieve Therapeutics and advance its gene therapy program to treat temporal lobe epilepsy (TLE)

Lexington, MA; Amsterdam, the Netherlands; and Paris, France, June 22, 2021 — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe me...

By  Pavankumar On  2021-06-23 19:45:00
Logo
Danaher aims to expand mRNA capabilities with $9.6 billion Aldevron acquisition

Danaher Corporation will acquire privately-held biotech firm Aldevron, for a cash purchase price of approximately $9.6 billion.  Fargo, North Dakota-based Aldevron was founded in 1998 by Michael Chamb...

By  Yashasvini On  2021-06-18 00:43:00
Logo
Synlogic enters research collaboration with Roche for development of Novel Therapy to treat InflammatoryBowel disease

Cambridge, Mass. (PR Newswire) June 17, 2021 – Synlogic, Inc. (Nasdaq: SYBX), a clinical stagecompany bringing the transformative potential of synthetic biology to medicine, announced today that it ha...

By  Pavankumar On  2021-06-17 17:49:00
Logo
CureVac may let contractors make rival vaccines if own shot fails

German biotech firm CureVac could allow its network of manufacturing partners to be repurposed to make vaccines developed by other companies should its own experimental shot fail, its chief executive ...

By  Kathi On  2021-06-17 09:47:00
Logo
Alzheimer’s drug by Biogen to be given to first patient

A US hospital will give the first infusion of the highly controversial Biogen's Alzheimer's drug on Wednesday. The drug, Aduhelm, will be administered for the first time outside of a clinical trial at...

By  Shubhangi On  2021-06-16 21:27:00
Logo
Aptinyx provides update on NYX-783 development program for the treatment of post-traumatic stress disorder

Aptinyx Inc. [APTX], a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced that it has finalized the design of i...

By  Reshma On  2021-06-16 09:16:00
Logo
New York to lift most Covid restrictions with 70% adults getting vaccinated

New York will lift most of the Covid-19 restrictions as 70 per cent of the adults in the state have been vaccinated with at least one dose, announced Gov. Andrew Cuomo on Tuesday. Cuomo said that the ...

By  Shubhangi On  2021-06-16 02:15:00
Logo
GlaxoSmithKline and iTeos sign $2 billion deal to develop cancer treatment

In a move to strengthen the pharmaceutical division's cancer pipeline, GlaxoSmithKline (GSK) has signed a $2 billion deal with US biotech iTeos Therapeutics. The two companies will work together to bu...

By  Yashasvini On  2021-06-14 23:28:00
Logo
Novavax covid-19 vaccine is 90% effective in key study

An experimental Covid-19 vaccine from Novavax Inc. (NVAX) was 90.4% effective at preventing symptomatic disease in adults in a large clinical trial, the company said, results that move the shot a step...

By  Divya On  2021-06-14 16:22:00
Logo
EMA official says AstraZeneca shots have good risk-benefit profile for over 60s

The head of the EU drug regulator's COVID-19 task force said on Sunday that AstraZeneca's [AZN] coronavirus vaccine had a favourable risk-benefit profile for all age groups and particularly for those ...

By  Reshma On  2021-06-14 10:52:00
Logo
Harvard veteran resigns from FDA panel amidst Alzheimer’s drug controversy

One more veteran has resigned from the US Food and Drug Administration advisory panel in the wake of Biogen's Alzheimer's drug Aduhelm getting approval from the agency. Harvard Medical School professo...

By  Shubhangi On  2021-06-12 01:19:00
Logo
FDA asks J&J to scrap 60 million doses of COVID-19 vaccine produced in Baltimore plant - NYT

The U.S. Food and Drug Administration have told Johnson & Johnson not to use about 60 million doses of its COVID-19 vaccine produced at a troubled Baltimore factory due to possible contamination, The ...

By  Arghyadeep On  2021-06-12 01:15:00
Logo
Brazil approves Pfizer Covid-19 vaccine for children over 12

Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer(PFE)/BioNtechCOVID-19vaccine for children over 12 years of age. Anvisa said it approved the measure after seeing studies...

By  Divya On  2021-06-11 18:23:00
Stock View